LifeMD (LFMDP) Competitors $24.00 +0.00 (+0.00%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LFMDP vs. ACONW, AONC, DHACW, FMS, OTRKP, PIIIW, TALKW, TOIIW, VSEE, and NTRAShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), and Natera (NTRA). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA Ontrak P3 Health Partners Talkspace Oncology Institute VSee Health Natera Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends. Which has stronger earnings & valuation, ACONW or LFMDP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/ALifeMD$245.56MN/AN/AN/AN/A Does the media prefer ACONW or LFMDP? In the previous week, Aclarion and Aclarion both had 1 articles in the media. Aclarion's average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral LifeMD Neutral Is ACONW or LFMDP more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A LifeMD N/A N/A N/A SummaryLifeMD beats Aclarion on 1 of the 1 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMDP vs. The Competition Export to ExcelMetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$346.22M$5.73B$9.76BDividend Yield11.99%5.90%4.40%4.08%P/E RatioN/A347.0330.3826.03Price / SalesN/A210.45428.56103.94Price / CashN/A47.1425.7828.79Price / BookN/A4.989.706.08Net IncomeN/A-$15.55M$3.27B$265.64M7 Day Performance1.10%0.63%3.95%3.11%1 Month Performance-0.08%0.67%3.81%0.39%1 Year Performance10.34%7.69%31.26%18.52% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDPLifeMDN/A$24.00flatN/A+8.2%$0.00$245.56M0.00230Positive NewsGap UpACONWAclarionN/A$0.04-2.3%N/A+16.2%$0.00$62.95K0.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$12.40+3.3%N/A+226.8%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/AGap DownFMSFresenius Medical Care AG & Co. KGaA2.8214 of 5 stars$24.96+0.5%$27.80+11.4%+30.1%$0.00$20.63B13.141,384OTRKPOntrakN/A$0.01+55.0%N/A-92.1%$0.00$10.84M0.00250PIIIWP3 Health PartnersN/A$0.01+16.2%N/AN/A$0.00$1.46B0.00500TALKWTalkspaceN/A$0.08-4.1%N/A+70.9%$0.00$202.61M0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.13-3.8%N/A+694.1%$0.00$424.38M0.00660Positive NewsGap DownVSEEVSee Health1.514 of 5 stars$0.77-4.8%$5.00+548.5%-51.5%$0.00N/A0.00N/AGap UpHigh Trading VolumeNTRANatera3.121 of 5 stars$160.12-0.6%$193.19+20.7%+32.4%$22.12B$1.70B0.004,434Positive News Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives VSEE Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMDP) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s national nightmare is hereWhile the headlines focus on global conflicts, there’s a very different crisis brewing at home. Washington has...Porter & Company | SponsoredIt’s game over for Central BanksCentral banks are losing control. Inflation isn’t fixed, debt is exploding, and stocks have never looked more ...Golden Portfolio | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access